Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drug 'increases risk' of carpel tunnel syndrome for cancer patients

  • Comment

Risk of carpal tunnel syndrome is higher in breast cancer patients given the drug exemestane than in those treated with tamoxifen, according to an international study in the Lancet Oncology.

Researchers looked at data from a study involving 4,700 women with early stage breast cancer.

Carpal tunnel syndrome was reported in 2.8% of 2,319 patients taking exemestane compared with 0.6% of 2,338 taking tamoxifen.

Those who developed the syndrome suffered it for six months on average.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.